Key Competitors - Influenza Vaccines Industry

Influenza is when an infection of the nose, throat and lungs. It is a respiratory infection that is contagious. Influenza is caused due to the influenza virus. The symptoms are Fever, Cough muscles and joint pain, and severe weakness. The infection can also lead to death. Influenza is commonly known as the flu. According to the World Health Organization (WHO), 2018, the number of people hospitalized due to influenza are approximately 3-5 million.

As of 2022, the global Influenza Vaccines Market is estimated to be valued at US$ 5,965.9 Million and is expected to exhibit a CAGR of 4.2% during the year (2022-2030).

Prominent Players in the Influenza Vaccines Industry:

1) AstraZeneca Plc.

AstraZeneca Plc. Is a multinational pharmaceutical and biotechnology company. The company is known for manufacturing products for major diseases like Oncology, Cardiovascular, Infection, Respiratory and Inflammation. Apart from that, it has also been a part of developing the Oxford-AstraZeneca Covid-19 vaccine. The company was founded in 1999 and the headquarters are located in Cambridge, England, UK.

In July of 2021 AstraZeneca completed the acquisition of Alexion Pharmaceuticals, Inc. In January of 2023, AstraZeneca also announced its plans to acquired CinCor a biopharmaceutical company based in the U.S.

2) Sanofi S.A.

Sanofi S.A. is a multinational pharmaceutical company that engages in the research and development, of pharmacological products, in the prescription market. The firm cover therapeutic areas like Cardiovascular, central nervous system, diabetes, internal medicine. The company was founded in 973 and the headquarters are located in Paris, France. Products manufactured include Medications, Genetic drugs, Vaccines, Animal Health, etc.

In December, 2022 Sanofi expanded its collaboration with Innate Pharma, with Sanofi licensing a natural killer (NK) cell nagger program targeting B7H3 from Innate’s ANKET platform.

3) GlaxoSmithKline GSK plc.

GSK Plc. Is a British Multinational pharmaceutical and biotechnology company founded in the year 2000. The headquarters are located in London, England, UK. GlaxoSmithKline is the tenth largest pharmaceutical company and has ranked 294^th on the 2002 Fortune Globes 500. The company was founded by Joseph Nathan. The company manufacture products for major diseases like asthma, cancer, infections and mental health.

In April 2022, the company announced its plans of acquiring Sierra Oncology Inc. for U.S$ 1.9 Billion. In May 2022, GSK announced it would acquire Affinivax and its phase II 24- Valent pneumococcal vaccine candidate for up to $3.3 Billion.

4) Moderna Inc.

Moderna Inc. is a pharmaceutical and biotechnological company situated in Cambridge. The company focuses on RNA therapeutics, primarily mRNA vaccines. The company’s pipeline include interleukin 12 for cancer immunotherapy, urothelial carcinoma, lymphoma etc. The company was founded in September 2010 by Derrick Rossi, Timothy A Springer, Robert S. Langer, Kenneth R. Chien, Noubar Afeyan. The headquarters are located in 200 Technology Square Cambridge Massachusetts, U.S.

In 2023, Moderna acquired OriCiro Genomics, a Japanese manufacturer of genetic engineering tools. In April 2022, Moderna announced to build a U.S.$ 180 million vaccine factory in Montreal, forming a partnership of 10 years with the government of Canada, McGill University and Quebec in order to produce 100 million Spikevax yearly.

5) BioCryst

 Pharmaceuticals, Inc.

BioCryst Pharmaceuticals. Inc. is a pharmaceutical company that focuses on oral drugs for very rare and comparatively serious diseases. The company manufactures an antiviral drug peramivir (Rapivab) which was approved by the FDA in the year 2014. The company was founded in the year 1986 and the headquarters are located in Durham, North Carolina, USA.